[Design of multiple targeted drugs]

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Context:

• Single-target drugs are insufficient for multigenic diseases (e.g., cancer) and multifactorial conditions (e.g., diabetes).
• Complex diseases require modulating multiple molecular targets for optimal therapeutic outcomes.
• The limitations of selective ligand action are increasingly recognized in modern medicine.

Purpose:

• To compare the disadvantages of selective ligands with the advantages of multi-target drugs.
• To introduce methodologies for designing multi-ligand drugs and their optimization.
• To highlight the challenges in developing drugs that act on multiple targets.

Summary:

• Multi-target drugs, impacting several targets simultaneously, are more effective for complex diseases and less prone to resistance.
• Designing multi-ligand drugs requires balancing activity across targets, ensuring selectivity, and optimizing pharmacokinetics.
• This approach presents a significant challenge for medicinal chemists, pharmacologists, toxicologists, and biochemists.

Impact:

• Multi-target drug design offers a superior therapeutic strategy over single-target approaches for complex diseases.
• Successful development of multi-target drugs can lead to improved treatment efficacy and reduced side effects.
• This paradigm shift necessitates interdisciplinary collaboration in drug discovery and development.